早发性痛风的系统遗传学分析:ABCG2是唯一相关基因座
研究纳入Aotearoa痛风遗传学研究1648例痛风患者,定义早发性痛风为首次发病年龄<40岁,检测10个与血清尿酸强相关的SNP。结果显示仅ABCG2 rs2231142 T等位基因与早发性痛风相关,在Eurogout和Ardea复制队列中验证,荟萃分析OR为1.60(95%CI 1.41-1.83)。
要点
- ABCG2 rs2231142 T等位基因与早发性痛风显著相关,荟萃分析OR=1.60(95%CI 1.41-1.83)。
- 其他9个血清尿酸相关SNP与早发性痛风无关联。
- 早发性痛风患者中ABCG2 rs2231142 T等位基因频率高于晚发性痛风患者。
核心结论
- 与其他升高血清尿酸的变异不同,ABCG2 rs2231142 T等位基因与早发性痛风强相关。
研究设计与样本
- 研究纳入Aotearoa痛风遗传学研究中1648例有基因分型的痛风患者,早发性痛风定义为首次痛风发作<40岁。
- 对10个与血清尿酸强相关的SNP进行基因分型,并在Eurogout(n=704)和Ardea(n=755)两个复制队列中验证及荟萃分析。
主要发现
- Aotearoa队列中638例(42.4%)为早发性痛风,ABCG2 rs2231142 T等位基因在早发性痛风组更常见。
- 其他检测的SNP在早发与晚发痛风组间风险等位基因数量无差异。
- 在未调整和调整模型(调整性别、BMI、痛风石、发作频率、血清肌酐和最高血清尿酸)中,ABCG2 rs2231142 T等位基因均与早发性痛风相关。
- 复制队列证实早发性痛风与ABCG2 rs2231142 T等位基因相关,与其他血清尿酸相关SNP无关。
- 荟萃分析中ABCG2 rs2231142 T等位基因对早发性痛风的OR为1.60(95%CI 1.41-1.83)。
关键数值与推荐
- 早发性痛风定义:首次痛风发作年龄<40岁。
- ABCG2 rs2231142 T等位基因与早发性痛风关联的荟萃分析OR=1.60(95%CI 1.41-1.83)。
临床怎么用
- 对于早发性痛风患者,可考虑检测ABCG2 rs2231142基因型以评估遗传风险。
- ABCG2 rs2231142 T等位基因携带者可能需更早关注痛风管理。
局限性
- 研究未报告其他潜在混杂因素或队列特异性限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to examine whether serum urate-associated genetic variants are associated with early-onset gout. METHODS: Participants with gout in the Genetics of Gout in Aotearoa study with available genotyping were included (n = 1648). Early-onset gout was defined as the first presentation of gout <40 years of age. Single nucleotide polymorphisms (SNPs) for the 10 loci most strongly associated with serum urate were genotyped. Allelic association of the SNPs with early-onset gout was tested using logistic regression in an unadjusted model and in a model adjusted for sex, body mass index, tophus presence, flare frequency, serum creatinine and highest serum urate. The analysis was also done in two replication cohorts: Eurogout (n = 704) and Ardea (n = 755), and data were meta-analysed. RESULTS: In the Genetics of Gout in Aotearoa study, there were 638 (42.4%) participants with early-onset gout. The ABCG2 rs2231142 gout risk T-allele was present more frequently in participants with early-onset gout compared with the later-onset group. For the other SNPs tested, no differences in risk allele number were observed. In the allelic association analysis, the ABCG2 rs2231142 T-allele was associated with early-onset gout in unadjusted and adjusted models. Analysis of the replication cohorts confirmed the association of early-onset gout with the ABCG2 rs2231142 T-allele, but not with other serum urate-associated SNPs. In the meta-analysis, the odds ratio (95% CI) for early-onset gout for the ABCG2 rs2231142 T-allele was 1.60 (1.41, 1.83). CONCLUSION: In contrast to other serum urate-raising variants, the ABCG2 rs2231142 T-allele is strongly associated with early-onset gout.
引用
- Zaidi F, Narang RK, Phipps-Green A, et al. Systematic genetic analysis of early-onset gout: ABCG2 is the only associated locus. Rheumatology (Oxford). 2020. PMID: 31998961. doi:10.1093/rheumatology/kez685
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。